ankylosing spondylitis
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Richard Staines
AbbVie, ankylosing spondylitis, Cosentyx, EULAR, Novartis, psoriatic arthritis, rheumatology
0 Comment
Swiss pharma hopes to bounce back from Q1 sales disappointment
X
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/
Market Access/ News/ News/ News/ R&D/ R&D/ US
Lilly aims for new indication for Taltz
Richard Staines
AbbVie, ankylosing spondylitis, Eli Lilly, inflammatory diseases, Novartis
0 Comment
X
Lilly aims for new indication for Taltz
https://pharmaphorum.com/news/eli-lilly-aims-new-indication-il-17-drug-taltz/